New insider activity at CVS Health ( (CVS) ) has taken place on August 29, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Director Anne Finucane recently sold 7,500 shares of CVS Health stock, generating a total of $532,650 from the transaction.
Spark’s Take on CVS Stock
According to Spark, TipRanks’ AI Analyst, CVS is a Outperform.
CVS Health’s strong technical momentum and positive earnings outlook are the most significant factors driving the score. While financial performance is solid, there is room for improvement in profitability. The valuation is reasonable, and the earnings call provided a positive outlook despite some challenges.
To see Spark’s full report on CVS stock, click here.
More about CVS Health
YTD Price Performance: 66.22%
Average Trading Volume: 7,397,182
Technical Sentiment Signal: Buy
Current Market Cap: $91.5B